These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 6837522

  • 1. Demonstration of bacteroides capsules by light microscopy and ultrastructural cytochemistry.
    Strohm H, Payne CM, Ryan KJ.
    Am J Clin Pathol; 1983 May; 79(5):591-7. PubMed ID: 6837522
    [Abstract] [Full Text] [Related]

  • 2. Encapsulated strains of Bacteroides fragilis in clinical specimens.
    Lindberg AA, Berthold P, Nord CE, Weintraub A.
    Med Microbiol Immunol; 1979 Mar 13; 167(1):29-36. PubMed ID: 440201
    [Abstract] [Full Text] [Related]

  • 3. Isolation and identification of encapsulated strains of Bacteroides fragilis.
    Kasper DL, Hayes ME, Reinap BG, Craft FO, Onderdonk AB, Polk BF.
    J Infect Dis; 1977 Jul 13; 136(1):75-81. PubMed ID: 328787
    [Abstract] [Full Text] [Related]

  • 4. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
    Kasper DL.
    J Infect Dis; 1976 Jan 13; 133(1):79-87. PubMed ID: 1451
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a direct fluorescent antibody staining method for rapid identification of members of the bacteroides fragilis group.
    DeGirolami PC, Mepani CP.
    Am J Clin Pathol; 1981 Jul 13; 76(1):78-82. PubMed ID: 7020409
    [Abstract] [Full Text] [Related]

  • 6. Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis.
    Kasper DL, Lindberg AA, Weintraub A, Onderdonk AB, Lönngren J.
    Rev Infect Dis; 1984 Jul 13; 6 Suppl 1():S25-9. PubMed ID: 6718939
    [Abstract] [Full Text] [Related]

  • 7. Pathogenicity of the Bacteroides fragilis group.
    Brook I.
    Ann Clin Lab Sci; 1989 Jul 13; 19(5):360-76. PubMed ID: 2679351
    [Abstract] [Full Text] [Related]

  • 8. Use of polymerase chain reaction fingerprinting to compare clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States.
    Claros MC, Hunt Gerardo S, Citron DM, Goldstein EJ, Schönian G, Rodloff AC.
    Clin Infect Dis; 1997 Sep 13; 25 Suppl 2():S295-8. PubMed ID: 9310712
    [Abstract] [Full Text] [Related]

  • 9. Surface structures, haemagglutination and cell surface hydrophobicity of Bacteroides fragilis strains.
    Oyston PC, Handley PS.
    J Gen Microbiol; 1990 May 13; 136(5):941-8. PubMed ID: 1696307
    [Abstract] [Full Text] [Related]

  • 10. [Selected properties of Bacteroides fragilis enterotoxigenic strains].
    Rokosz A, Meisel-Mikołajczyk F.
    Med Dosw Mikrobiol; 1995 May 13; 47(3-4):183-8. PubMed ID: 8833930
    [Abstract] [Full Text] [Related]

  • 11. [Bacteroides and appendicitis (author's transl)].
    Werner H, Kunstek-Santos H, Schockemöhle C, Gündürewa M.
    Pathol Microbiol (Basel); 1975 May 13; 42(2):110-8. PubMed ID: 1178229
    [Abstract] [Full Text] [Related]

  • 12. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL, Onderdonk AB.
    Scand J Infect Dis Suppl; 1982 May 13; 31():28-33. PubMed ID: 6954635
    [Abstract] [Full Text] [Related]

  • 13. An electron microscopic study of surface polysaccharides in Bacteroides.
    Dahlén G, Nygren H.
    Microbios; 1982 May 13; 35(140):119-29. PubMed ID: 6186892
    [Abstract] [Full Text] [Related]

  • 14. Separation of capsulate and non-capsulate Bacteroides fragilis on a discontinuous density gradient.
    Patrick S, Reid JH.
    J Med Microbiol; 1983 May 13; 16(2):239-41. PubMed ID: 6842574
    [No Abstract] [Full Text] [Related]

  • 15. Adherence of Bacteroides fragilis in vivo.
    Onderdonk AB, Moon NE, Kasper DL, Bartlett JG.
    Infect Immun; 1978 Mar 13; 19(3):1083-7. PubMed ID: 640723
    [Abstract] [Full Text] [Related]

  • 16. Quantitative variability in requirements for opsonization of strains within the Bacteroides fragilis group.
    Bjornson AB, Bjornson HS, Ashraf M, Lang TJ.
    J Infect Dis; 1983 Oct 13; 148(4):667-75. PubMed ID: 6631060
    [Abstract] [Full Text] [Related]

  • 17. The growth and survival of capsulate and non-capsulate Bacteroides fragilis in vivo and in vitro.
    Patrick S, Reid JH, Larkin MJ.
    J Med Microbiol; 1984 Jun 13; 17(3):237-46. PubMed ID: 6726783
    [Abstract] [Full Text] [Related]

  • 18. Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization.
    Kasper DL, Weintraub A, Lindberg AA, Lönngren J.
    J Bacteriol; 1983 Feb 13; 153(2):991-7. PubMed ID: 6185469
    [Abstract] [Full Text] [Related]

  • 19. gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.
    Oh H, El Amin N, Davies T, Appelbaum PC, Edlund C.
    Antimicrob Agents Chemother; 2001 Jul 13; 45(7):1977-81. PubMed ID: 11408211
    [Abstract] [Full Text] [Related]

  • 20. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
    Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG.
    J Infect Dis; 1977 Jul 13; 136(1):82-9. PubMed ID: 886206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.